FDA declines to approve Acer Therapeutics’ treatment for rare genetic disorder

The treatment, Edsivo, aims to treat vascular Ehlers-Danlos syndrome (vEDS)- the most severe type of a hereditary disorder of the connective tissue.

Original source: https://health.economictimes.indiatimes.com/news/pharma/fda-declines-to-approve-acer-therapeutics-treatment-for-rare-genetic-disorder/69945128?utm_source=RSS&utm_medium=ETRSS

Related Posts